Key result
Body surface mapping departure maps revealed that the +2SD area correlated well with the sum of septal and posterior wall thickness, allowing estimation of the extent of myocardial hypertrophy.
Why the study?
Does body surface mapping correlate with the site and degree of myocardial hypertrophy in patients with non-obstructive hypertrophic cardiomyopathy?
Cross-Sectional (n=64)
Does body surface mapping correlate with the site and degree of myocardial hypertrophy in patients with non-obstructive hypertrophic cardiomyopathy?
Body surface mapping departure maps correlate well with echocardiographic wall thickness, allowing for the estimation of the site and degree of myocardial hypertrophy in non-obstructive hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support body surface mapping for hypertrophy assessment in non-obstructive HCM; leaves open clinical adoption without prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (1992) conducted a cross-sectional in Non-obstructive hypertrophic cardiomyopathy (n=64). Body surface mapping vs. Healthy controls was evaluated on Correlation between the +2SD area on the departure map and the sum of septal and posterior wall thickness (r=0.63-0.81). Body surface mapping departure maps revealed that the +2SD area correlated well with the sum of septal and posterior wall thickness, allowing estimation of the extent of myocardial hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: